Detalhe da pesquisa
1.
Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study.
Mov Disord
; 37(7): 1516-1525, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607776
2.
Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study.
BMC Neurol
; 17(1): 129, 2017 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28676085
3.
Safety and effectiveness of CIMAvax-EGF administered in community polyclinics.
Front Oncol
; 13: 1287902, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38304035
4.
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC.
Front Oncol
; 12: 958043, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35992783
5.
The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer.
Front Oncol
; 11: 639745, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211836